... strategy of using combo drugs Gilead built its empire on two major treatments -- the flu treatment Tamiflu and the HIV/AIDS treatment Viread. Tamiflu is licensed to Roche , which pays Gilead 10% in royalties on global sales. However, Tamiflu's main ...
http://www.fool.com/investing/general/2013/09/26/why-is-this-large-biotech-company-a-sound-investme.aspx
http://www.fool.com/investing/general/2013/09/26/why-is-this-large-biotech-company-a-sound-investme.aspx
No comments:
Post a Comment